Dori, A.; Guglieri, M.; Scutifero, M.; Passamano, L.; Trabacca, L.; Politano, L. Can Symptomatic NmDuchenne Carriers Benefit from Treatment With Ataluren? Results of 193-Month Follow-up. Acta Myol 2022, 41.